Learn More
Medchemexpress LLC Ipatasertib dihydrochloride | 1396257-94-5 | C24H34Cl3N5O2 | 2 MG

Supplier: Medchemexpress LLC HY15186A2MG
Ipatasertib dihydrochloride is a highly selective, ATP-competitive pan-Akt inhibitor targeting Akt1, Akt2, and Akt3 with IC50s of 5, 18, and 8 nM, respectively. This compound demonstrates significant selectivity for Akt1 over PKA (more than 600-fold) and p70S6K (over 100-fold). In broader kinase profiling, it inhibits only PRKG1α, PRKG1β, and p70S6K by more than 70% at 1 μM concentration.
- Highly selective, ATP-competitive pan-Akt inhibitor
- Inhibits Akt1, Akt2, and Akt3 with high potency
- Demonstrates significant selectivity for Akt1 over PKA and p70S6K
- Inhibits PRKG1α, PRKG1β, and p70S6K at 1 μM
- Intended for research use only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.